Silvercrest Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29M Sell
75,073
-217
-0.3% -$80.5K 0.19% 150
2026
Q1
$22M Buy
75,290
+1,431
+2% +$470K 0.16% 180
2025
Q4
$25.9M Buy
73,859
+13,921
+23% +$4.7M 0.18% 161
2025
Q3
$19.4M Buy
59,938
+18,117
+43% +$5.63M 0.13% 211
2025
Q2
$16.3M Buy
41,821
+86
+0.2% +$34.6K 0.11% 231
2025
Q1
$18.2M Buy
41,735
+2,616
+7% +$1.05M 0.13% 200
2024
Q4
$14.4M Buy
+39,119
New +$16.4M 0.1% 232

Other funds holding ELV

Silvercrest Asset Management's ELV Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Elevance Health (ELV) stake by 0.29% in Q2 2026, selling an estimated $80.5K and leaving 75,073 shares worth $29M. The position accounts for 0.19% of the portfolio, ranked #150.

Silvercrest Asset Management first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Silvercrest Asset Management held 75,073 shares of Elevance Health worth $29M as of Q2 2026.
  • Silvercrest Asset Management sold 217 Elevance Health shares in Q2 2026, an estimated $80.5K.
  • Elevance Health made up 0.19% of Silvercrest Asset Management's portfolio in Q2 2026, its #150 holding.
  • Silvercrest Asset Management first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.